SRM Hospital chosen for human trials of COVID-19 vaccine
Kattankulathur, 05 Jul:
SRM Medical College Hospital and Research Centre (SRM MCHRC), Kattankulathur has been selected by Indian Council for Medical Research (ICMR) as a clinical trial site of the country's first indigenous COVID-19 vaccine (BBV152 COVID Vaccine).
SRM Medical College Hospital and Research Centre is one among the 12 institutions in India to have been son chosen. The vaccine has been developed by ICMR- National Institute of Virology, Pune, which has partnered with Bharat Biotech International limited, Hyderabad.
SRM MCHRC is also the only medical institution to be selected from Tamil Nadu for this purpose. Associate Professor from the Department of Pharmacology, Dr Satyajith Mohapatra, SRM Medical College Hospital and Research Centre has been chosen as the Principal Investigator for these clinical trials at SRM MCHRC.